Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jun 5;5(2):e1057386.
doi: 10.1080/2162402X.2015.1057386. eCollection 2016 Feb.

The beneficial effects of a gas-permeable flask for expansion of Tumor-Infiltrating lymphocytes as reflected in their mitochondrial function and respiration capacity

Affiliations

The beneficial effects of a gas-permeable flask for expansion of Tumor-Infiltrating lymphocytes as reflected in their mitochondrial function and respiration capacity

Marie-Andrée Forget et al. Oncoimmunology. .

Abstract

Adoptive transfer of autologous ex vivo expanded tumor-infiltrating lymphocytes (TIL) is a highly successful cell therapy approach in the treatment of late-stage melanoma. Notwithstanding the success of this therapy, only very few centers worldwide can provide it. To make this therapy broadly available, one of the major obstacles to overcome is the complexity of culturing the TIL. Recently, major efforts have been deployed to resolve this issue. The use of the Gas-permeable flask (G-Rex) during the REP has been one application that has facilitated this process. Here we show that the use of this new device is able to rescue poor TIL growth and maintain clonal diversity while supporting an improved mitochondrial function.

Keywords: TIL ACT; gas-permeable membrane; mitochondrial function; oxidative phenotype; tumor-infiltrating lymphocytes.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Assessment of TIL growth after rapid expansion in the traditional flask and bag vs. Gas-permeable flask (G-Rex) reveals a trend toward improved TIL expansion when using the G-Rex flask. (A) Fold expansion of post-REP TIL lines expanded shows a trend toward a better expansion when using the G-Rex. N = 10. (B) The G-Rex flask facilitates the expansion of TIL lines from which the growth is impaired in the REP using the traditional flask and bag devices N = 4. Statistical significance was determined by using a paired t-test.
Figure 2.
Figure 2.
Rapid expansion of TIL in the Gas-permeable flask (G-Rex) does not favor selection and expansion of specific T cell clones. Clonal diversity was evaluated by measurement of the expression of major TCR α and β chain gene by the NanoString nCounter® technology. The analysis of the level of expression of 45 Vα and 46 Vβ genes in RNA isolated from the pre-REP TIL lines in comparison with the different expansion devices demonstrated no difference in the clonal diversity obtained post REP. Two out of 4 TIL lines from 4 melanoma patients are shown. Statistical analysis using a Spearman correlation comparing cells grown in traditional flask and bag (red) vs. Gas-permeable flask (blue) is shown for both Vα and Vβ genes.
Figure 3.
Figure 3.
Bioenergetic analysis of melanoma TIL lines to evaluate mitochondrial function. (A–D) OCR of 4 TIL lines on day 7 of the REP (A and B) or sorted, pre-REP CD8+BTLA+ and CD8+BTLA TIL line from 3 patients (C and D) were determined using a Seahorse XP96 Bioanalyzer. OCR were calculated after 3 min of mix time and 4 min of measurement time. OCR[Mito] is the total mitochondrial OCR, the value just prior to the Oligomycin (OLG) injection minus the non-mitochonddrial OCR component determine by Antimycin (AA) treatment. OCR[OLG] is the component of the OCR that is sensitive to Oligomycin treatment, the rate used by ATP-syntase. The OCR on a per cell basis was determined by dividing the OCR by the seeded TIL count of 250000. (E) OCR/ECAR ratio is the OCR[OLG] divided by the ECAR basal which is reflextive of a cell dependence on glycolysis. (F) pre-REP TIL were stained using a MitoTracker dye. The MFI of the MitoTracker staining of the CD8+BTLA+ and CD8+BTLA subset from 3 TIL lines is shown. The histogram shows staining of a representative TIL line. Statistical significance was determined by using a paired t-test.

References

    1. Dudley ME, Wunderlich JR, Yang JC, Sherry RM, Topalian SL, Restifo NP, Royal RE, Kammula U, White DE, Mavroukakis SA et al.. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clin Oncol 2005; 23:2346-57; PMID:15800326; http://dx.doi.org/10.1200/JCO.2005.00.240 - DOI - PMC - PubMed
    1. Besser MJ, Shapira-Frommer R, Treves AJ, Zippel D, Itzhaki O, Hershkovitz L, Levy D, Kubi A, Hovav E, Chermoshniuk N et al.. Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients. Clin Cancer Res 2010; 16:2646-55; PMID:20406835; http://dx.doi.org/10.1158/1078-0432.CCR-10-0041 - DOI - PubMed
    1. Radvanyi LG, Bernatchez C, Zhang M, Fox PS, Miller P, Chacon J, Wu R, Lizee G, Mahoney S, Alvarado G et al.. Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients. Clin Cancer Res 2012; 18:6758-70; PMID:23032743; http://dx.doi.org/10.1158/1078-0432.CCR-12-1177 - DOI - PMC - PubMed
    1. Dudley ME, Wunderlich JR, Robbins PF, Yang JC, Hwu P, Schwartzentruber DJ, Topalian SL, Sherry R, Restifo NP, Hubicki AM et al.. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 2002; 298:850-4; PMID:12242449; http://dx.doi.org/10.1126/science.1076514 - DOI - PMC - PubMed
    1. Jin J, Sabatino M, Somerville R, Wilson JR, Dudley ME, Stroncek DF, Rosenberg SA. Simplified method of the growth of human tumor infiltrating lymphocytes in gas-permeable flasks to numbers needed for patient treatment. CA J Immunother 2012; 35:283-92; PMID:22421946; http://dx.doi.org/10.1097/CJI.0b013e31824e801f - DOI - PMC - PubMed

Publication types

LinkOut - more resources